The steady approval of new biosimilars in recent years provides additional safe, effective, and cost-effective options for ...
Results of a meta-analysis showed that all biologic agents were superior to placebo for improving short-term outcomes in moderate to severe plaque psoriasis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback